The 3 analysts offering 12-month price forecasts for Fulgent Genetics Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a +0.06% increase from the last price of 17.99.
The current consensus among 3 polled investment analysts is to Buy stock in Fulgent Genetics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.